The “best” way to identify clinically significant, localized prostate cancer continues to evolve. But there is still no consensus about what that “best” way might be to do this, let alone any consensus about the detection of “clinically insignificant”, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, Diagnosis, MRi-guided, risk, systematic | Leave a comment »
According to a newly published paper in European Urology, a simple, hour-long lecture and training session can improve the ability of physicians to counsel patients systematically about active sureveillance and, at one major center, improved patient acceptance of active surveillance by as much as 17 percent. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, choice, counseling, negotiation, surveillance, systematic | 1 Comment »
A significant number of patients have wanted to believe that, with the coming of targeted biopsies based on multiparametric MRI imaging, the need for “random” systematic biopsies (e.g., standard 10- or 12-core biopsies) would go away. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: fusion-guided, MRI, MRI/TRUS, multiparametric, systematic, targeted | 6 Comments »
An important article by Siddiqui et al. appears in this week’s issue of the Journal of the American Medical Association. It deals with the experience of Dr. Peter Pinto and his colleagues in the diagnosis of prostate cancer in about 1,000 patients over the past few years. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: biopsy, fusion, MRI, MRI/TRUS, standard, systematic | Leave a comment »
An article just published in the Journal of Urology argues that, ” The gold standard for cancer detection in primary biopsy is [now] a combination of systematic and targeted cores.” . READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, MRI, MRI/TRUS fusion, systematic, targeted | 1 Comment »
Contrast-enhanced, transrectal ultrasound (CE-TRUS) technology has been found to better detect high-grade prostate cancer than conventional forms of TRUS, which may make it a more appropriate method for the diagnosis of clinically important cancers and monitoring low-risk ones with less biopsies. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: biopsy, CE-TRUS, contrast-enhanced, Diagnosis, systematic, targeted, transrectal, TRUS, ultrasound | 2 Comments »
Here in the USA there has been a nucleus of physicians who have argued for years that the use of color Doppler ultrasound enhances the ability to identify and biopsy prostate cancer. New data from Germany are relevant to this conversation. … READ MORE …
Filed under: Diagnosis, Management | Tagged: biopsy, color Döppler, systematic, ultrasound | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 